1. Home
  2. TISI vs ATYR Comparison

TISI vs ATYR Comparison

Compare TISI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Team Inc.

TISI

Team Inc.

N/A

Current Price

$16.19

Market Cap

71.4M

ML Signal

N/A

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.85

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TISI
ATYR
Founded
1973
2005
Country
United States
United States
Employees
6800
58
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.4M
73.7M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TISI
ATYR
Price
$16.19
$0.85
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$4.20
AVG Volume (30 Days)
6.8K
1.0M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$896,483,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.19
N/A
52 Week Low
$12.34
$0.64
52 Week High
$24.20
$7.29

Technical Indicators

Market Signals
Indicator
TISI
ATYR
Relative Strength Index (RSI) 58.37 50.68
Support Level $13.27 $0.67
Resistance Level $16.62 $0.85
Average True Range (ATR) 0.93 0.05
MACD 0.14 -0.00
Stochastic Oscillator 72.19 68.91

Price Performance

Historical Comparison
TISI
ATYR

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: